Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection

Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection

We conducted subanalyses of the combined results of the Maraviroc versus Optimized Therapy in Viremic Antiretroviral Treatment-Experienced Patients (MOTIVATE) 1 and MOTIVATE 2 studies to better characterize the efficacy and safety of maraviroc in key subgroups of patients.We analyzed pooled data fro...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Gerd Fätkenheuer, Mark Nelson, Adriano Lazzarin, Irina Konourina, Andy I. M. Hoepelman, Harry Lampiris, Bernard Hirschel, Pablo Tebas, François Raffi, Benoît Trottier, Nicholaos Bellos, Michael S. Saag, David A. Cooper, Mike Westby, Margaret Tawadrous, John F. Sullivan, Caroline E. Ridgway, Michael W. Dunne, Steve Felstead, Howard Mayer, Elna van der Ryst
Format: Artigo
Jezik:angleščina
Izdano: 2008
Online dostop:https://doi.org/10.1056/nejmoa0803154
https://www.nejm.org/doi/pdf/10.1056/NEJMoa0803154?articleTools=true
Oznake: Označite
Brez oznak, prvi označite!

Internet

https://doi.org/10.1056/nejmoa0803154
https://www.nejm.org/doi/pdf/10.1056/NEJMoa0803154?articleTools=true

Podobne knjige/članki